A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer.
about
Immunodetection of human topoisomerase I-DNA covalent complexesA phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol.The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer CellsGenome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells.Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.Pro-Angiogenic Effects of Low Dose Ethoxidine in a Murine Model of Ischemic Hindlimb: Correlation between Ethoxidine Levels and Increased Activation of the Nitric Oxide Pathway.Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer.Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.Topoisomerase I as a biomarker: detection of activity at the single molecule level.Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice.A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.Drug transporters in breast cancer: response to anthracyclines and taxanes.Etirinotecan pegol for the treatment of breast cancer.Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer.RBBP6 expressional effects on cell proliferation and apoptosis in breast cancer cell lines with distinct p53 statuses
P2860
Q27324108-666D3F1F-963F-4BAA-B28B-280283320AE4Q35125726-E07E8FB5-02E6-4849-9D05-C14C5BEA781FQ35683541-125D9F15-7FD0-4E06-921E-5B1745FA5FDAQ35740932-8460CAA4-9A41-4AF8-A8A3-5EDA03C3BE77Q35902206-0606F8D6-A6AB-42E6-9A68-3EA825743590Q36349412-3C041D37-C293-46B0-B349-784F13DFA5BEQ36618871-8462C0A8-7D1D-4185-8AB8-551F2627AF48Q37046332-8AE58920-BBE9-45C1-9E88-79C2A971F1A7Q37413146-FF163246-FD71-4CD3-B5E8-0EC6FD2523BBQ37588708-13E58FEA-05B2-45E7-B403-8C7E91D393DFQ37718417-07E8DA7A-3241-490E-B95E-64C8AA02B154Q38248193-80AEF183-9595-4693-8DEB-187317B3BC0FQ38575008-AE1710EA-3B2A-4ADF-AB7E-843E982F1DA0Q38735361-4D660A03-2E9A-40B1-AA60-EEF5D2BBBB3AQ41953738-9963EBB8-C558-40C0-AB5E-BE87315E8D2BQ53552603-D2507204-5184-485D-9B00-828580DB29F2Q58754519-60FAAD76-DDFA-4D3C-8C29-698077D1405A
P2860
A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review on topoiso ...... t of metastatic breast cancer.
@en
type
label
A systematic review on topoiso ...... t of metastatic breast cancer.
@en
prefLabel
A systematic review on topoiso ...... t of metastatic breast cancer.
@en
P2093
P2860
P1476
A systematic review on topoiso ...... t of metastatic breast cancer.
@en
P2093
Dorte L Nielsen
Eva Balslev
Iben Kümler
Jan Stenvang
Nils Brünner
P2860
P2888
P304
P356
10.1007/S10549-013-2476-3
P407
P577
2013-03-20T00:00:00Z
P6179
1015446780